University of Colorado Denver

Public research footprint of University of Colorado Denver, compiled from the ClinicalTrials.gov public registry.

724

Registered studies

119

Active

Recruiting now

466

Completed

117

Stopped or withdrawn

Most-studied conditions

Lupus Erythematosus, Systemic · Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor… · FTD With Amyotrophic Lateral Sclerosis (FTD/ALS) · Lymphoma, Large B-Cell, Diffuse

Recently updated registry entries

NCT07085104 — A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR… (Recruiting)
NCT06750094 — A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… (Recruiting)
NCT05352919 — An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059)… (Enrolling By Invitation)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Colorado Denver?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.